TechNVision, Solix, and Symbiosis sign MoU to create an AI-powered Center of Excellence for new drug development and repurposing, focusing on Alzheimer's and antimicrobial resistance.
AI Assistant
TechNVision Ventures Ltd
2026
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.